Similar articles for PMID: 16319512

Year	Number of Results
1996	1
2001	2
2003	1
2004	4
2005	8
2006	4
2007	12
2008	6
2009	9
2010	8
2011	6
2012	5
2013	1
2014	1
2015	4
2016	1
2017	1
2020	3
2021	2
2024	0

1

Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes.

Donadio M, Ardine M, Berruti A, Beano A, Bottini A, Mistrangelo M, Bonardi S, Castiglione F, Generali D, Polimeni MA, Bretti S, Alabiso O, Bertetto O; Piemonte Oncology Network. Donadio M, et al. Oncology. 2005;69(5):408-13. doi: 10.1159/000089995. Epub 2005 Nov 24. Oncology. 2005. PMID: 16319512

2

Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.

Jones A, O'Brien M, Sommer H, Nowara E, Welt A, Pienkowski T, Rolski J, Pham ML, Perraud K, Trillet-Lenoir V. Jones A, et al. Cancer Chemother Pharmacol. 2010 Mar;65(4):755-63. doi: 10.1007/s00280-009-1081-y. Epub 2009 Aug 9. Cancer Chemother Pharmacol. 2010. PMID: 19669644 Clinical Trial.

3

Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

Fan Y, Xu B, Yuan P, Wang J, Ma F, Li Q, Zhang P, Li Q, Cai R. Fan Y, et al. Chemotherapy. 2010;56(4):340-7. doi: 10.1159/000320186. Epub 2010 Aug 18. Chemotherapy. 2010. PMID: 20720418 Clinical Trial.

4

Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes.

Schaller G, Fuchs I, Gonsch T, Weber J, Kleine-Tebbe A, Klare P, Hindenburg HJ, Lakner V, Hinke A, Bangemann N. Schaller G, et al. J Clin Oncol. 2007 Aug 1;25(22):3246-50. doi: 10.1200/JCO.2006.09.6826. Epub 2007 Jun 18. J Clin Oncol. 2007. PMID: 17577021 Clinical Trial.

5

Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes.

Hortobagyi GN, Gomez HL, Li RK, Chung HC, Fein LE, Chan VF, Jassem J, Lerzo GL, Pivot XB, Hurtado de Mendoza F, Xu B, Vahdat LT, Peck RA, Mukhopadhyay P, Roché HH. Hortobagyi GN, et al. Breast Cancer Res Treat. 2010 Jul;122(2):409-18. doi: 10.1007/s10549-010-0901-4. Epub 2010 May 8. Breast Cancer Res Treat. 2010. PMID: 20454927 Clinical Trial.

6

Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer.

Wang HQ, Qian ZZ, Liu XM, Zhang HL, Li LF, Qiu LH, Hou Y, Zhou SY, Hao XS, Xie CH. Wang HQ, et al. Chin Med J (Engl). 2010 Nov;123(22):3212-6. Chin Med J (Engl). 2010. PMID: 21163117 Clinical Trial.

7

Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer.

Massacesi C, La Cesa A, Marcucci F, Pilone A, Rocchi MB, Zepponi L, Santini D, Tonini G, Burattini L. Massacesi C, et al. Oncology. 2006;70(4):294-300. doi: 10.1159/000096250. Epub 2006 Oct 12. Oncology. 2006. PMID: 17047400 Clinical Trial.

8

A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.

Campone M, Isambert N, Bourbouloux E, Roché H, Bonneterre J, Milano G, Fumoleau P. Campone M, et al. Cancer Chemother Pharmacol. 2012 Apr;69(4):871-9. doi: 10.1007/s00280-011-1767-9. Epub 2011 Nov 2. Cancer Chemother Pharmacol. 2012. PMID: 22045498 Clinical Trial.

9

A Phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

Estévez LG, Batista N, Sánchez-Rovira P, Velasco A, Provencio M, León A, Dómine M, Cruz J, Rodríguez M. Estévez LG, et al. Clin Breast Cancer. 2008 Apr;8(2):149-54. doi: 10.3816/CBC.2008.n.015. Clin Breast Cancer. 2008. PMID: 18621611 Clinical Trial.

10

A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study.

Villanueva C, Awada A, Campone M, Machiels JP, Besse T, Magherini E, Dubin F, Semiond D, Pivot X. Villanueva C, et al. Eur J Cancer. 2011 May;47(7):1037-45. doi: 10.1016/j.ejca.2011.01.001. Epub 2011 Feb 19. Eur J Cancer. 2011. PMID: 21339064 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

67 results

Results by year